Research and Practice in Thrombosis and Haemostasis (May 2021)

A case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene

  • Eman M. Mansory,
  • Pratibha Bhai,
  • Alan Stuart,
  • Lori Laudenbach,
  • Bekim Sadikovic,
  • Alejandro Lazo‐Langner

DOI
https://doi.org/10.1002/rth2.12510
Journal volume & issue
Vol. 5, no. 4
pp. n/a – n/a

Abstract

Read online

Abstract Congenital prothrombin deficiency is an extremely rare, autosomal recessive bleeding disorder with a prevalence of 1 in 2 million individuals. Here, we report a case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene (F2), affecting the heavy B chain. The patient presented with a history of multiple bleeding events in his youth that are mostly trauma associated, with a family history of prothrombin deficiency. Laboratory analysis showed a prolonged activated partial thromboplastin time and a prothrombin activity level of 5%. Genetic analysis of the F2 gene identified two heterozygous variants; one is a previously reported pathogenic deletion (c.1814_1815del; p.His605Argfs*13), and the other is a novel missense variant (c.1147C>T; p.Arg383Trp). In silico analysis predicted that p.Arg383Trp is likely to be disease causing, as it affects one of the anion‐binding exosites‐I of the B chain. This case highlights the significance of molecular findings in confirming the diagnosis of patients with congenital prothrombin deficiency.

Keywords